Supplementary Figure S8. An intact adaptive immune response is necessary for efficacy triple therapy in neu/N mice. from A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice